Home | Community | Get Involved | Donate | | Site Index | Search Go Button
The mark, American Cancer Society, is a registered trademark of the American Cancer Society, Inc., and may not be copied, reproduced, transmitted, displayed, performed, distributed, sublicensed, altered, stored for subsequent use or otherwise used in whole or in part in any manner without ACS's prior written consent.
 
My Planner Register | Sign In Sign In


ACS News Center
 
    Medical Updates
    News You Can Use
    Stories of Hope
    ACS Archives
    ACS News Center Staff
   
   
   
    I Want to Help
  You can help in the fight against cancer. Donate and volunteer.
  Learn more
   
Drug Prevents Chemotherapy-induced Hearing Loss in Lab Studies
Researchers Look to the Future to Protect the Inner Ear
Article date: 2001/09/14
cisplatindrip
Lesser-known side effects of some chemotherapy drugs include hearing losss.

Many patients are receiving chemotherapy today to fight and overcome cancer. These powerful drugs, however, do have significant side effects and many are well known to the public such as hair loss, nausea, and weight loss.

A lesser-known and potentially permanent side effect of some commonly used drugs, such as cisplatin, is hearing impairment. And usually the higher the dose of the medication, the more likely the result is damage. High doses are frequently used to fight cancer.

Loss of hearing, even partial, is a significant disability as it lessens a patient’s ability to communicate. This is especially troublesome during and after a serious illness, as a connection with a “circle of friends” is so critical to recovery.

Natural Substance Used to Protect the Inner Ear

Findings from a study by Joseph Feghali, MD; Wei Liu, BS; and Thomas Van De Water PhD, from the Albert Einstein College of Medicine, were reported in a recent issue of The Laryngoscope (Vol. 111:1148-1155). These scientists conducted an experiment in the laboratory using tissue culture techniques allowing inner ear cells and their connecting nerve filaments to grow.

These growing cells were then exposed to the chemotherapy drug cisplatin. The drug was found to severely damage these cells. However, when they added a natural substance called L-NAC to the cells before the chemotherapy drug cisplatin, the cells were protected and able to grow. ( L-NAC is a form of acetyl cysteine, an antioxidant and scavenger of oxygen-rich “radicals,” chemicals formed during various phases of our metabolism).

Scientists Look to the Lab for Early Hope

This study represents a first laboratory step to combat one treatment’s side effect. Additional research studies need to be done before a treatment recommendation can be made to patients. However, scientists can now focus on this area of research and perhaps build on the findings to develop clinical evidence that eventually benefits patients.


Writer: Ivo Janecka, MD, FACS
Editors: Sarah Goodwin and Dama Laurie

ACS News Center stories are provided as a source of cancer-related news and are not intended to be used as press releases.
Printer-Friendly Page
Email this Page
Related Tools & Topics
Bookstore  
Learn About Cancer  
Prevention & Early Detection  
Not registered yet?
  Register now or see reasons to register.  
Help |  About ACS |  Employment & Volunteer Opportunities |  Legal & Privacy Information |  Press Room
Copyright 2009 © American Cancer Society, Inc.
All content and works posted on this website are owned and
copyrighted by the American Cancer Society, Inc. All rights reserved.